| # | Drug | Count |
|---|---|---|
| 0 | RAMIPRIL | 41 |
| 1 | DICLOFENAC SODIUM | 40 |
| 2 | RITUXIMAB | 40 |
| 3 | SECUKINUMAB | 40 |
| 4 | DICLOFENAC | 39 |
| 5 | OXYCODONE | 36 |
| 6 | PREDNISONE | 36 |
| 7 | TOFACITINIB | 36 |
| 8 | LEFLUNOMIDE | 35 |
| 9 | METHOTREXATE SODIUM | 35 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MINERAL OIL AND PETROLATUM | 1 | 0.0714 |
| 1 | HYDROCORTISONE BUTYRATE | 12 | 0.0061 |
| 2 | DICLOFENAC POTASSIUM TABLETS | 28 | 0.0032 |
| 3 | DESOGESTREL AND ETHINYL ESTRADIOL | 10 | 0.0031 |
| 4 | GOLIMUMAB | 33 | 0.0026 |
| 5 | DICLOFENAC POTASSIUM | 28 | 0.0025 |
| 6 | PIROXICAM | 16 | 0.0025 |
| 7 | PSEUDOEPHEDRINE HCL | 24 | 0.0022 |
| 8 | CAFFEINE CITRATE | 5 | 0.0021 |
| 9 | TRICLOSAN | 1 | 0.0017 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 52 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 43 |
| 2 | Angiotensin Converting Enzyme Inhibitor [EPC] | 41 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 40 |
| 4 | Interleukin-17A Antagonist [EPC] | 40 |
| 5 | Vitamin C [EPC] | 38 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 36 |
| 7 | Antirheumatic Agent [EPC] | 35 |
| 8 | Aminosalicylate [EPC] | 34 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 34 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 7 | 0.0102 |
| 1 | Endoglycosidase [EPC] | 15 | 0.0081 |
| 2 | Interleukin-17A Antagonist [EPC] | 40 | 0.0011 |
| 3 | Provitamin D2 Compound [EPC] | 23 | 0.0008 |
| 4 | Antiseptic [EPC] | 3 | 0.0007 |
| 5 | Glucosylceramide Synthase Inhibitor [EPC] | 1 | 0.0004 |
| 6 | Aminosalicylate [EPC] | 34 | 0.0003 |
| 7 | Antirheumatic Agent [EPC] | 35 | 0.0003 |
| 8 | Interleukin-12 Antagonist [EPC] | 32 | 0.0003 |
| 9 | Interleukin-23 Antagonist [EPC] | 32 | 0.0003 |